← Back
$SGMO All transactions

SANGAMO THERAPEUTICS, INC

F

$ Value

$25K

Shares

31,866

Price

$1

Filed

Apr 24

Insider

Name

Dubois-Stringfellow Nathalie

Title

SVP-CHIEF DEVELOPMENT OFFICER

CIK

0001947007

Roles

Officer

Transaction Details

Transaction Date

2025-04-22

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

801,539

Footnotes

Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on April 22, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on April 22, 2025 of $0.7763/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise. | Includes: (a) 57,196 shares resulting from the April 22, 2025 vesting installment of the Reporting Person's January 22, 2024 RSU grant, and the remaining 267,188 shares will vest in successive equal quarterly installments through January 22, 2026, (b) 20,039 shares subject to Reporting Person's February 24, 2023 RSU grant that will vest in successive equal quarterly installments through February 24, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-fourth (1/4) of the shares subject to the grant on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.

Filing Info

Accession No.

0001415889-25-011281

Form Type

4

Issuer CIK

0001001233

Dubois-Stringfellow Nathalie's History

Date Ticker Type Value
2026-04-21 SGMO $89K
2026-04-01 SGMO A $0
2025-07-22 SGMO F $15K
2025-05-24 SGMO F $848
2025-04-22 SGMO F $25K

Other Insiders at SGMO (90d)

Insider Bought Sold Last
Macrae Sandy
PRESIDENT, CEO AND DIRECTOR
2026-04-01
Willoughby Scott B.
SVP, CHIEF LEGAL OFFICER, SECY
2026-04-01
Dubois-Stringfellow Nathalie
SVP-CHIEF DEVELOPMENT OFFICER
$89K 2026-04-21
Davis Gregory D
Head of Research & Technology
$18K 2026-04-22
Jain Nikunj
Principal Accounting Officer
2026-04-01